|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/04 | (2006.01) |
| A61K 39/25 | (2006.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61P 31/22 | (2006.01) |
| (11) | Number of the document | 2281831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10188256.1 |
| Date of filing the European patent application | 2006-03-01 | |
| (97) | Date of publication of the European application | 2011-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation | 2018-07-10 |
| (30) | Number | Date | Country code |
| 0504436 | 2005-03-03 | GB |
| (72) |
Hanon, Emmanuel Jules, BE
Stephenne, Jean, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Varicella Zoster viruso vakcina |
| Varicella Zoster virus vaccine |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 20 | 347.00 EUR |